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Transient receptor potential melastatin 2 (TRPM2) is a Ca2+-perme-
able cation channel expressed in immune cells of phagocytic line-
age, pancreatic β cells, and brain neurons and is activated under
oxidative stress. TRPM2 activity is required for immune cell activa-
tion and insulin secretion and is responsible for postischemic neu-
ronal cell death. TRPM2 is opened by binding of ADP ribose (ADPR)
to its C-terminal cytosolic nudix-type motif 9 (NUDT9)-homology
(NUDT9-H) domain, which, when expressed in isolation, cleaves
ADPR into AMP and ribose-5-phosphate. A suggested coupling of
this enzymatic activity to channel gating implied a potentially ir-
reversible gating cycle, which is a unique feature of a small group
of channel enzymes known to date. The significance of such a cou-
pling lies in the conceptually distinct pharmacologic strategies for
modulating the open probability of channels obeying equilibrium
versus nonequilibrium gating mechanisms. Here we examine the
potential coupling of TRPM2 enzymatic activity to pore gating.
Mutation of several residues proposed to enhance or eliminate
NUDT9-H catalytic activity all failed to affect channel gating kinetics.
An ADPR analog, α-β-methylene-ADPR (AMPCPR), was shown to be
entirely resistant to hydrolysis by NUDT9, but nevertheless sup-
ported TRPM2 channel gating, albeit with reduced apparent affinity.
The rate of channel deactivation was not slowed but, rather, accel-
erated in AMPCPR. These findings, as well as detailed analyses of
steady-state gating kinetics of single channels recorded in the pres-
ence of a range of concentrations of ADPR or AMPCPR, identify
TRPM2 as a simple ligand-gated channel that obeys an equilibrium
gating mechanism uncoupled from its enzymatic activity.
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Transient receptor potential melastatin 2 (TRPM2) belongs tothe TRP protein family and is abundantly expressed in brain
neurons, bone marrow, phagocytes, pancreatic β cells, and car-
diomyocytes, where it forms Ca2+-permeable nonselective cation
channels that open under oxidative stress. On contact with
pathogens, phagocytic cells produce reactive oxygen species
(ROS); the resulting activation of TRPM2 provides the Ca2+ influx
necessary for cell migration and chemokine production (1). In
pancreatic β cells, TRPM2 activity contributes to glucose-evoked
insulin secretion; TRPM2 knock-out mice show higher resting
blood glucose levels and impaired glucose tolerance (2).
TRPM2 activity is also linked to several pathologic conditions
that lead to apoptosis (3). Reperfusion after ischemia results in
ROS generation; consequent Ca2+ influx through TRPM2 causes
Ca2+ dysregulation and cell death. Certain neurodegenerative
diseases, such as Alzheimer’s disease, also involve oxidative
stress and TRPM2 activation. In contrast, a loss-of-function
TRPM2 mutation identified in patients with amyotrophic lateral
sclerosis and Parkinson’s disease dementia (4), as well as two
TRPM2 mutations associated with bipolar disorder (5), suggest
loss of TRPM2 activity can also cause disease.
Similar to most TRP family ion channels, the TRPM2 channel
is a homotetramer, and its transmembrane (TM) architecture
resembles that of voltage-gated cation channels (6, 7). In addi-
tion to the TM domain and an N-terminal cytosolic domain of
unknown function, TRPM2 contains an ∼270-residue C-terminal
cytosolic nudix-type motif 9 (NUDT9)-homology (NUDT9-H)
domain. The latter shows high (∼50%) sequence homology to
the soluble mitochondrial enzyme NUDT9, an active ADP ri-
bose (ADPR) pyrophosphatase (ADPRase) from the Nudix
hydrolase family, which splits ADPR into AMP and ribose-5-
phosphate (8). TRPM2 channels are coactivated by ADPR
binding to NUDT9-H (9) and by Ca2+ binding to unidentified
intracellular binding sites (10). ADPR is the key that links
TRPM2 activation to oxidative stress; in living cells exposed to
ROS, ADPR is released from mitochondria (9). In the past,
studying TRPM2 channel gating at steady state has been limited
by rapid deactivation of TRPM2 currents in cell-free patches
(10). This rundown was recently shown to involve a conforma-
tional change of the ion selectivity filter, which could be com-
pletely prevented by a pore-loop substitution. This “T5L”
TRPM2 variant, which shows no rundown but preserves intact
regulation of gating by Ca2+ and ADPR (11), provides an un-
precedented opportunity to study TRPM2 gating at steady state.
Early studies reported slow (∼0.1 s−1) but detectable ADPRase
activity of isolated purified NUDT9-H (8, 12), classifying TRPM2
into the special group of channel-enzymes (“chanzymes”) that
includes TRPM6 and TRPM7 (3) and the CFTR cystic fibrosis
transmembrane conductance regulator (CFTR) chloride ion chan-
nel (13). TRPM2 pore opening/closure happens on the timescale of
the reported ADPRase activity (11), which is consistent with cou-
pling between gating and catalytic activity, as demonstrated for
CFTR in which pore gating follows an irreversible cycle tightly
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linked to ATP binding and hydrolysis at conserved cytosolic
domains (14).
The involvement of TRPM2 in multiple diseases has made it
an emerging therapeutic target. Depending on the disease, both
inhibition (e.g., stroke, myocardial infarction, Alzheimer’s dis-
ease, chronic inflammation, hyperinsulinism) and stimulation
(e.g., diabetes, amyotrophic lateral sclerosis, Parkinson’s disease
dementia, bipolar disorder) of TRPM2 activity might be useful
therapeutically. Because TRP family channels are involved in
diverse processes (3), any useful TRPM2 agonists/antagonists
will need to be highly selective. This singles out the NUDT9-H
domain, the component unique to TRPM2, as the most attrac-
tive drug target. The significance of understanding whether
ADPRase activity and gating are coupled is that optimal strat-
egies for modulating fractional occupancy of a particular con-
formational state are profoundly different for equilibrium
systems than for nonequilibrium systems. For most ion channels,
pore gating is an equilibrium process, and open probability is
modulated simply by energetic stabilization of either open
(activators) or closed (inhibitors) channel ground states. In
contrast, channels that gate by a nonequilibrium cycle are most
efficiently accumulated in either open or closed states by ma-
nipulating the stability of transition states for rate-limiting irre-
versible steps (15). The aim of this study was to examine the
tightness of coupling between the ADPRase cycle and specific
gating transitions in TRPM2.
Results
Mutations of Residues Key for Catalysis in Nudix Family Enzymes Have
Little Effect on TRPM2 Channel Gating. In inside-out patches, in the
presence of saturating (125 μM) intracellular Ca2+, wild-type
(WT) TRPM2 currents are activated by cytosolic ADPR with an
apparent affinity of ∼1 μM (Fig. 1 A and G; cf. refs. 10, 16) and
deactivate slowly, with a time constant of ∼2 s, on rapid removal
of ADPR (Fig. 1A, green fit line, and Fig. 1K; cf. ref. 11).
Fractional activity in 1 μM ADPR reports ADPR binding af-
finity, whereas the slow current decay rate (∼0.5 s−1) on ADPR
removal is on the order of the ADPRase turnover rate reported
(12) for the purified NUDT9-H domain (∼0.1 s−1), supporting
a suggested (8) link between the enzymatic cycle and gating. The
time constant of this current decay reflects the lifetime of an
“active conformation” of the NUDT9-H domain; exit from this
“active state” might correspond to dissociation of intact ADPR,
ADPR hydrolysis, or perhaps dissociation of the hydrolysis
products. We therefore tested how these macroscopic gating
parameters are affected by catalytic site mutations.
All Nudix family enzymes contain the conserved Nudix box
sequence motif GX5EX7REX2EE, which forms a loop–helix
structure essential for correct positioning of the substrate’s py-
rophosphate moiety and catalytic Mg2+ ions (17) (Fig. S1). Di-
vergence of the terminal six residues of this motif between
NUDT9 and NUDT9-H (R229EFGEE234 in NUDT9, but
R1404ILRQE1409 in NUDT9-H; Fig. 1B) was found responsible
(12, 17) for the ∼100-fold lower catalytic activity of the latter
enzyme. Notably, in a crystal structure of NUDT9, the side chain
of residue E230 coordinates the Mg2+ ion (17) (Fig. S1). The
REF→RIL substitution reduced NUDT9 enzymatic activity by
100-fold (12, 17), and substitution EE→KK of the terminal two
Nudix-box residues completely abolished it (12). By analogy, the
QE→KK substitution of the terminal two Nudix-box residues
in single-mutant Q1408K and E1409K and double-mutant
Q1408K/E1409K TRPM2 channels may be expected to abolish
ADPRase activity of NUDT9-H. However, neither substitution
slowed channel deactivation (Fig. 1 D–F and K), and only the
double-mutation Q1408K/E1409K modestly decreased the ap-
parent affinity for current activation by ADPR (Fig. 1 F and G).
Conversely, in an attempt to enhance the slow ADPRase activity
of NUDT9-H, we regenerated the canonical REF motif in
TRPM2 by introducing mutations I1405E, L1406F, and I1405E/
L1406F. Both single mutants and the double mutant generated
macroscopic ADPR-induced currents (Fig. 1 H–J), and none of
these substitutions affected fractional activation by 1 μM ADPR
(Fig. 1G) or deactivation rate after ADPR removal (Fig. 1K).
Note that deactivation should have been accelerated if these
Fig. 1. Mutations of residues proposed to be key for catalysis have little effect on TRPM2 channel gating. (A, C, D–F, H–J) Inward macroscopic currents elicited
by application of 125 μM Ca2+ (black bars) plus 1 or 32 μM ADPR (gray staggered bars) to the cytosolic faces of inside-out patches excised from Xenopus oocytes
expressing human (A) WT, (C) D1468A, (D) Q1408K, (E) E1409K, (F) Q1408K/E1409K, (H) I1405E, (I) L1406F, and (J) I1405E/L1406F TRPM2 channels. Colored lines,
single exponential fits to current relaxation time courses; τ, time constants. (B) Sequence alignment of NUDT9 and NUDT9-H Nudix boxes highlighting residues
functionally important in NUDT9. (G) Fractional current activation (mean ± SEM) by 1 μM ADPR for WT and mutant TRPM2; steady current in 1 μM ADPR was
normalized to that in 32 μM ADPR in the same patch. (K) Deactivation time constants (mean ± SEM) after ADPR removal, from single-exponential fits.
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mutations accelerated ADPR hydrolysis and the latter rate lim-
ited channel closure.
Finally, D1468 of TRPM2 aligns with the catalytic base of
Escherichia coli ADPRase. Although mutation of the diacidic
motif at the analogous position of NUDT9 (D304/D305; Fig. 1B)
reduced its ADPRase activity by ∼15-fold (17), D1468A TRPM2
channels expressed well (Fig. 1C) and yielded channels with
gating parameters indistinguishable from WT (Fig. 1 G and K).
TRPM2 Channel Activation Is Not Linked to Ligand Hydrolysis. Our
mutational results suggested that ADPR hydrolysis might not be
linked to channel gating. However, the catalytic mechanisms of
Nudix enzymes are known to have diverged (17), leaving room
for the alternative possibility that other residues are responsible
for catalysis in NUDT9-H. As a complementary approach,
therefore, we tested whether a nonhydrolyzable ADPR analog,
α-β-methylene-ADPR (AMPCPR; ref. 18; Fig. 2B; the oxygen
bridging the α and β phosphates is replaced by a methylene
group), would support channel gating. We used the soluble and
highly active NUDT9 protein (Fig. S2B) to verify resistance of
AMPCPR to hydrolysis. Indeed, incubation of NUDT9 with
AMPCPR did not result in the appearance of breakdown
products, whereas ADPR was stoichiometrically converted into
AMP and ribose-5-phosphate (Fig. 2A). In inside-out patches,
cytosolic application of AMPCPR activated TRPM2 currents in
a dose-dependent manner (Fig. 3B; in these and all subsequent
experiments, we used the noninactivating T5L pore mutant,
which allowed for longer experiments and, thus, repeated ap-
plication of various tested nucleotides). However, the apparent
affinity for current activation was ∼40-fold lower relative to
ADPR (Fig. 3A), and currents elicited by a quasi-saturating
concentration of 400 μM AMPCPR remained only ∼50% of
those activated by a saturating concentration (32 μM) of ADPR
(Fig. 3C, red versus blue symbols and fit lines). Thus, AMPCPR
is a low-affinity partial agonist of TRPM2. The fact that a non-
hydrolyzable analog readily opens TRPM2 channels clearly
demonstrates that ligand hydrolysis is not required for TRPM2
channel opening.
TRPM2 Channel Deactivation Is Not Linked to Ligand Hydrolysis. To
probe any potential requirement for ligand hydrolysis in TRPM2
channel deactivation, we tested whether macroscopic deactivation
rate on sudden nucleotide removal is slowed for the non-
hydrolyzable analog. On the contrary, deactivation after AMPCPR
removal was accelerated ∼threefold relative to that on removal of
ADPR (Fig. 4), suggesting that the lifetime of the activated state is
not terminated by ligand hydrolysis. Of note, CFTR channels, in
which pore closure is coupled to hydrolysis of the native ligand ATP
(19), nevertheless close promptly when opened by the non-
hydrolyzable analog adenylyl imidodiphosphate (AMPPNP), but
they are arrested in the open state on binding of one ATP and one
AMPPNP in ATP/AMPPNP mixtures (19). However, TRPM2
channels opened by ADPR/AMPCPR mixtures deactivated at rates
intermediate between those measured for the two nucleotides, and
no “locked-open” channels could be detected even under such
conditions (Fig. S3), further supporting the conclusion that ligand
hydrolysis is not required for TRPM2 channel closure.
Bursting Pattern of Single-Channel Activity in Saturating ADPR
Suggests Two Types of Gate Closures. To better understand the
mechanism by which ADPR gates TRPM2 channels, we studied
the pattern of steady-state single-channel gating at low (1 μM)
and high (32 μM) concentrations of ADPR (Fig. 5 A and B).
Although the distributions of open dwell times (Fig. 5 C and D,
Right) were reasonably fit by single exponentials (red lines),
fitting the closed-time distributions required at least two ex-
ponential components (Fig. 5 C and D, Left, red fit lines), sug-
gesting the presence of at least two types of closed states. [A
simple C↔Omodel (Fig. 5E, blue dashed box) was inadequate to
describe either data set (Fig. 5 C and D, blue dashed fit lines)
and could be excluded with strong confidence at both concen-
trations of ADPR (P = 2 × 10−25 and 2 × 10−45, respectively).]
The result is a bursting gating pattern, with bursts of openings
interrupted by brief (“flickery”) closures and flanked by longer
(“interburst”) closures (Fig. 5 A and B; cf. ref. 10). In saturating
ADPR, the mean duration of interburst closures was shortened
but remained distinctly longer than that of flickery closures. Thus,
entering a burst is not caused by ligand binding itself but, instead,
reflects a conformational change after ligand binding, which
becomes rate-limiting at high ADPR concentrations. To model
gating of fully liganded TRPM2, we chose the three-state scheme
Cs*↔O*↔Cf* (Fig. 5E, red box; Cs*, O*, and Cf* are fully liganded
closed-interburst, open, and flickery closed states, respectively; see
Discussion for further support of this choice).
Reduced Stability of the Bursting State Explains Reduced Efficacy for
Channel Activation by AMPCPR. Although, because of the slow
gating rates, only a few transitions could be collected from any
single channel recording (Fig. 5), patches with multiple channels
provided sufficient gating events (Fig. S4) to reliably extract (see
Materials and Methods) single-channel open probabilities (Po;
Fig. 6A) and mean open burst (τb; Fig. 6B) and interburst (τib;
Fig. 6C) durations over a range of concentrations of activating
nucleotide, using either ADPR (blue) or AMPCPR (red) as the
ligand. The reduced apparent affinity of AMPCPR for stimu-
lating Po (Fig. 6A, red versus blue symbols and fit lines), which
Fig. 2. AMPCPR is resistant to hydrolysis. (A) TLC analysis of ADPR, AMP,
and AMPCPR samples before (−) and after (+) incubation with purified
NUDT9 (see SI Materials and Methods). ADPR is degraded into AMP and
ribose-5-phosphate; the latter is not visible on the TLC. (B) Structures of ADPR
and AMPCPR. Vertical arrow highlights the oxygen bridge in ADPR that is
cleaved by NUDT9.
Fig. 3. Nonhydrolyzable ADPR analog is a low-affinity partial TRPM2
channel agonist. (A and B) T5L-TRPM2 currents are stimulated in a dose-
dependent manner by cytosolic application of either (A) 0.32, 1, 3.2, 10, and
32 μM ADPR (blue staggered bar) or (B) 10, 32, and 200 μM AMPCPR (red
staggered bar) in the presence of saturating cytosolic Ca2+ (black bars).
Currents elicited in the same patches by saturating (32 μM) ADPR (blue bars)
were used for normalization. (C) Normalized dose–response curves (mean ±
SEM) for stimulation of macroscopic T5L-TRPM2 current by ADPR (blue
symbols; replotted from ref. 11) and AMPCPR (red symbols). Solid lines are
fits to the Hill equation.
Tóth et al. PNAS | November 25, 2014 | vol. 111 | no. 47 | 16951
PH
YS
IO
LO
G
Y
replicated the observations on macroscopic currents (Fig. 3C),
was caused by a reduced apparent affinity for shortening τib (Fig.
6C), whereas τb (Fig. 6B) showed little dependence on agonist
concentration. This suggests a reduced affinity of AMPCPR for
binding to closed channels (Figs. 5E and 6G; step Cs↔Cs*). In
contrast, the reduced efficacy of AMPCPR originated from
a distinct kinetic effect: Whereas at saturating AMPCPR, τib
asymptotically approached that measured in saturating ADPR
(∼1 s; Fig. 6C, red versus blue fit lines), τb remained ∼threefold
shorter (∼1.5 s in AMPCPR versus ∼5 s in ADPR; Fig. 6B, red
versus blue symbols). In the framework of the Cs*↔O*↔Cf*
gating scheme, these findings are explained by alteration (rela-
tive to ADPR) of a single rate, a ∼threefold acceleration of rate
O*→Cs* with AMPCPR (to ∼0.7 s−1; Fig. 6G). Furthermore,
this scheme also predicts several effects on intraburst behavior for
AMPCPR: acceleration of rateO*→Cs* should entail a shortened
mean open time [τo = (rateO*→Cs*+rateO*→Cf*)−1] and a reduced
average number of flickery closures per burst (nf = rateO*→Cf*/
rateO*→Cs*), but unaltered mean flickery closed time duration
[τf = (rateCf*→O*)−1], all of which are readily observable in the data
(Fig. 6 D, F, and E, respectively; red versus blue symbols).
What is the nature of the Cs*→O* conformational transition
that initiates a channel open burst? Activating ligands stabilize
the open state because they bind more tightly when the pore is
open. In extreme cases, such as for the CFTR channel, the ag-
onist is fully occluded and cannot be washed off while the
channel is open. As a consequence, the mean open (burst) du-
ration is insensitive to agonist concentration (19) and is identical
to the time constant of macroscopic current deactivation after
ligand removal (14). For TRPM2, τb and τo also do not depend
strongly on [ADPR], but a slight trend for shorter τb and τo at very
low, submicromolar nucleotide concentrations (Fig. 6 B and D, blue
and red symbols) suggests that ADPR might not be completely
occluded but remains somewhat exchangeable, even in open chan-
nels (Fig. 6G, semitransparent states O and Cf), although the open-
state affinity for ADPR is much higher, as for a conventional ligand-
gated channel. Indeed, macroscopic deactivation time constants (Fig.
4 and Fig. S5A) and mean open times measured during the de-
activation time course (Fig. S4B) extend the plots in Fig. 6 B and D
and reflect τb and τo at zero agonist concentration (Fig. S5 C andD).
Discussion
Ion channels are passive devices: When open, they allow diffu-
sion of ions down their electrochemical gradient, a process that
does not require energy input. For most ion channels, the gating
conformational changes that open and close the pore are at
thermal equilibrium and are not coupled to irreversible enzy-
matic reactions. Few exceptions to this rule exist. The only ion
channel for which gating has been shown to be linked to an ir-
reversible ATP hydrolysis cycle is the CFTR chloride ion
channel, which belongs to the family of ATP Binding Cassette
transporters and likely inherited this trait from an ancestral active
pump (14). TRPM6 and TRPM7 contain an active kinase domain
at their C termini, but the link between kinase activity and channel
gating is unclear (20). The discovery of the ADPRase activity of the
TRPM2 NUDT9-H domain (8) placed TRPM2 into the small
group of chanzymes, raising the intriguing possibility that its gating
might also be linked to an irreversible enzymatic cycle.
Parallel biochemical studies on NUDT9 and on the isolated
NUDT9-H domain highlighted residues of importance for ca-
talysis. The two orders of magnitude difference between catalytic
rates of NUDT9 (∼10 s−1) and NUDT9-H (∼0.1 s−1) were
explained by divergent sequences in the conserved Nudix motif
(Fig. 1B and Fig. S1). Converting this motif in NUDT9 to
a NUDT9-H-like sequence (REF→RIL substitution) indeed
lowered NUDT9 catalytic turnover rate by ∼100-fold (12). In
addition, the reverse RIL→REF substitution in full-length
TRPM2 abolished ADPR-induced whole-cell currents (21),
which was interpreted to reflect acceleration of ADPR hydrolysis
and, hence, limited residence time of the nucleotide on NUDT9-H.
Although a double lysine substitution for the terminal two
Nudix box residues that eliminated ADPRase activity of NUDT9
(12) did not abolish whole-cell channel currents when introduced
into full-length TRPM2 (9), potential dramatic alterations in
gating kinetics were not assessed, leaving room for a possible
coupling between catalysis and gating. Indeed, for CFTR chlo-
ride channels in which pore closure is coupled to ATP hydrolysis,
certain mutations that impair catalysis slow closure by ∼100-fold,
but do not reduce open probability (13, 19). In our experiments,
RIL→REF substituted channels supported large ADPR-evoked
currents with gating parameters indistinguishable from WT (Fig.
1 H–J). We attribute the lack of activity in the earlier study (21)
to misfolding/misprocessing of the mutant protein in mammalian
cells at 37 °C, but not in Xenopus oocytes incubated at 18 °C. We
found the double lysine substitution Q1408K/E1409K to also
allow robust functional surface expression (Fig. 1F; cf. ref. 9)
and, with the exception of a slightly reduced apparent affinity for
Fig. 4. Nonhydrolyzable ligand does not slow TRPM2 channel deactivation.
(A and B) Decay time courses on nucleotide removal of macroscopic T5L-
TRPM2 currents activated by quasi-saturating concentrations of (A) ADPR or
(B) AMPCPR in the presence of saturating Ca2+. Colored lines, single-expo-
nential fits; τ, time constants. (C) Mean ± SEM deactivation time constants of
T5L-TRPM2 channels opened by ADPR and AMPCPR.
Fig. 5. Bursting gating pattern of single T5L-TRPM2 channels is evident
even in saturating ADPR. (A and B) Current recordings from single T5L-
TRPM2 channels in 125 μM cytosolic Ca2+ and (A) 1 or (B) 32 μM ADPR.
Dashed lines, zero-current level. (C and D) Histograms (22) of closed (Left)
and open (Right) dwell times of single channels gating in (C) 1 or (D) 32 μM
ADPR, from the recordings in A and B, respectively. Dashed blue and solid
red lines are maximum-likelihood fits to the dwell-time distributions by
subsets of the scheme in E, framed in respective colors. Log-likelihood ratios
(ΔLL) allow rejection of the C↔O model with significance P (29); similar ΔLL
values (31.5–310.1) were obtained in six further single-channel patches. (E)
Simplest gating scheme compatible with the dwell-time distributions. Boxed
subsets generate identically colored fits in C and D. Asterisks mark fully
liganded states. Cs*, long (slow) closed state; O*, open state; Cf*, brief
(flickery) closed state. Horizontal dashed double arrow connects unliganded
(Cs) and fully liganded (Cs*) long closed states and represents sequential
binding of four ligands.
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ADPR (Fig. 1G), gating of this double mutant again remained
similar to WT. Finally, we tested the role of residue D1468,
which aligns with the catalytic base of the E. coli ADPRase (17),
but D1468A TRPM2 gating also remained indistinguishable
from WT (Fig. 1 C, G, and K).
As an alternative approach for probing the role of ADPR
hydrolysis, we used the nonhydrolyzable analog AMPCPR (ref.
18; Fig. 2B), which we confirmed to be indeed completely re-
sistant to hydrolysis, even by NUDT9 (Fig. 2A), an ADPRase
∼100-fold more active than NUDT9-H (Fig. 2A). The non-
hydrolyzable analog readily opened TRPM2 channels (Fig. 3B),
albeit with reduced apparent affinity (Fig. 3C), and did not arrest
the channels in the active (bursting) state, as indicated by an
even accelerated deactivation rate on its removal (Fig. 4 B and C,
red bar). In principle, the ADPR-induced active state might be
more stable and require ligand hydrolysis for its prompt disas-
sembly, whereas the AMPCPR-induced bursting state might be
less stable and disassemble promptly, even without ligand hy-
drolysis. If that were the case, and hydrolysis of the four bound
ADPR molecules was a concerted process [note that in-
dependent sequential hydrolysis would be expected to cause
a sigmoidal deactivation time course, unlike the exponential
relaxations observed here (e.g., Fig. 4A)], then binding of
AMPCPR in only one subunit might be sufficient to prevent
hydrolysis of ADPR in the other three, whereas bursting-state
stability would be still dominated by the three native high-affinity
ligands, causing prolonged arrest in the bursting state (cf. ref.
19). However, no such population of locked-open channels was
detected in ADPR/AMPCPR mixtures (Fig. S3A); the observed
intermediate deactivation rate (Fig. S3B) suggests simple ener-
getically additive effects of all four bound nucleotides on burst-
ing-state stability. Together, these results firmly establish that
neither activation (entering a burst) nor deactivation (exiting
a burst) of TRPM2 is linked to ligand hydrolysis: TRPM2 is
a conventional ligand-gated channel, and its gating conforma-
tional changes are at thermodynamic equilibrium.
At least one open and two closed states could be resolved in
single-channel dwell-time histograms, even at saturating ADPR
(Fig. 5D), requiring a three-state scheme as a minimal gating
model for fully liganded channels. Such a bursting gating pattern
is equally well explained by a Cs*↔Cf*↔O* (CCO) or a
Cs*↔O*↔Cf* (COC) scheme (22), but two arguments favor the
COC choice here (Fig. 5E). First, whereas the COC scheme
implies distinct slow and fast channel gates, the CCO scheme
assumes a single gate, the opening of which is modeled by the
Cf*→O* step. Therefore, for channels obeying the latter mech-
anism, partial agonists that are inefficient in opening the channel
often prolong the mean dwell time in the Cf* state (e.g., ref. 23);
that is, the mean flickery closed time duration (τf). In contrast,
for TRPM2, τf was unaltered in the presence of the partial ag-
onist AMPCPR (Fig. 6E), suggesting the presence of two distinct
gates: a slow gate regulated by nucleotide binding and an in-
dependent fast gate. Second, the COC scheme is also supported
by the argument of parsimony: Using this scheme, the complex
effects of AMPCPR on burst length (shortened τb; Fig. 6B) and
intraburst kinetic parameters [shortened τo (Fig. 6D), unchanged
τf (Fig. 6E), and reduced nf (Fig. 6F)] are all explained by al-
teration of a single rate (acceleration of rateO*→Cs*; Fig. 6G),
whereas the CCO scheme would require simultaneous alterations
in three rates (increased rateCf*→Cs*, slowed rateCf*→O*, increased
rateO*→Cf*) to achieve this result. Thus, the reduced (relative to
ADPR) efficacy of AMPCPR is caused by less-efficient stabiliza-
tion of state O* relative to Cs*.
On the basis of structural proximity of the NUDT9-H domain
to the C-terminal end of the sixth TM α-helix (TM6), the nucle-
otide-activated slow gate is likely the TM6 bundle crossing that
forms an intracellular gate in other members of the voltage-gated
channel family [(6, 7); Fig. 6G, lower gate]; in other channels, this
gate is regulated by intracellular agonists such as Ca2+ (24),
phospholipids (25), or intracellular nucleotides (26). In contrast,
the nucleotide-independent fast gate underlying the brief flickery
closures might be formed by the extracellular selectivity filter (Fig.
6G, upper gate), which causes C-type inactivation of voltage-gated
K+ channels (27) and rundown of WT TRPM2 (11).
The scheme in Fig. 5E is a minimal scheme that accounts for
many of our observations, but it allows for nucleotide binding/
unbinding only in the closed state. However, deactivation time
constants after nucleotide removal (Fig. 4) were consistently
shorter than steady-state τb in saturating nucleotide (Fig. 6B), and
a modest but significant trend for shortened steady-state τb was
Fig. 6. Detailed kinetic analysis reveals molecular mechanism of nucleotide-dependent channel activation. (A–F) Dose–response curves (mean ± SEM) of (A)
Po, (B) τb, (C) τib, (D) τo, (E) τf, and (F) nf, for T5L-TRPM2 channels gating at steady state in 125 μM Ca2+ plus various concentrations of ADPR or AMPCPR (blue
and red symbols, respectively), extracted by maximum-likelihood fitting of 199 well-resolved multichannel recordings from 124 patches (see Materials and
Methods and Fig. S4). Note that τb is a function of the intraburst parameters in D–F (equation in red box). Solid lines in A are fits to the Hill equation [Po =
Po;∞·([L]
n/([L]n+Kn)]; those in C are fits to the inverse of the Hill equation [τib = ([L]n+Kn)/([L]n·τib;∞)]. Fit parameters were (A) Po;∞ = 0.75 ± 0.03, K = 2.1 ± 0.3
μM, n = 1.0 ± 0.1 for ADPR and Po;∞ = 0.41 ± 0.02, K = 48 ± 6 μM, n = 2.5 ± 0.5 for AMPCPR; (C) τib;∞ = 1.0 ± 0.2 s, K = 7.1 ± 1.9 μM, n = 1.5 ± 0.1 for ADPR and
τib;∞ = 1.8 ± 0.8 s, K = 83 ± 45 μM, n = 1.4 ± 0.1 for AMPCPR. (G) Cartoon, molecular interpretation of nucleotide-dependent TRPM2 gating. Numbers on
vertical transitions are rates (s−1). Blue, TM domain; upper constriction, selectivity filter; lower constriction, TM6 bundle crossing; red, NUDT9H domains;
purple, activating nucleotides; yellow, Ca2+; green, Na+. Incomplete occlusion of the nucleotide might allow for ligand release in the bursting state (to
putative states depicted in faint print).
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observed at lower, submicromolar concentrations of ADPR (Fig.
6B, blue symbols). Because the rates of activation are very slow at
these low ligand concentrations (τib>>τb; cf. Fig. 6 B and C),
macroscopic relaxation time constants on sudden lowering of
ADPR concentration from saturating (32 μM) to 0.1 or 0.32 μM
roughly measure the rates of deactivation at such submicromolar
ADPR. Such relaxation time constants (τrelax; Fig. S5A) were
identical to τb measured at steady-state in 0.1 or 0.32 μM ADPR
(Fig. S5C, open versus closed symbols), confirming that τrelax on
complete nucleotide removal (Fig. 4) indeed measures τb at zero
ligand concentration. Although activation by ADPR necessarily
implies that the nucleotide must be bound more tightly in the
bursting state, this detectable ADPR concentration dependence of
τb suggests incomplete occlusion of the ligand, with slow ex-
changeability even in the bursting state (i.e., the likely existence of
unliganded states O and Cf, shown as semitransparent states in
Fig. 6G). In contrast, coactivating Ca2+ ions were shown to remain
at rapid equilibrium with the bulk cytosolic solution, even while
a TRPM2 channel is open (10).
In conclusion, we have shown that TRPM2 is a conventional
ligand-gated channel activated by ligand binding, and none of the
observable gating transitions is coupled to the irreversible ADPR
hydrolysis cycle reportedly catalyzed by its NUDT9-H domain. A
practical consequence of this mechanism is that it outlines an
obligate strategy for the design of specific TRPM2 modulators
acting on the NUDT9-H domain: Activators should stabilize the
bursting state by binding more tightly to bursting channels,
whereas inhibitors should do the opposite (i.e., bind more tightly
to closed channels). Further studies will need to verify enzymatic
activity of the NUDT9-H domain, in isolation and in intact
TRPM2 channels, as well as determine its physiologic relevance.
Materials and Methods
Molecular Biology. Mutations were introduced into TRPM2-pGEMHE (10)
using Stratagene Quikchange. Linearized (NheI; New England BioLabs) cDNA
was transcribed in vitro using T7 polymerase; cRNA was stored at −80 °C.
Isolation and Injection of Xenopus Oocytes. Xenopus oocytes were collage-
nase-digested, injected with 0.1–10 ng cRNA (for single-channel and mac-
roscopic recordings, respectively), and stored at 18 °C. Recordings were done
1–3 d after injection.
Excised Inside-Out Patch-Clamp Recording. Pipette solution contained (in mM)
140 Na-gluconate, 2 Mg-gluconate2, 10 Hepes (at pH 7.4 with NaOH; free
[Ca2+] ∼4 μM; the pipette electrode was placed into a 140-mM NaCl-based
solution carefully layered on top] (10). Bath solution contained (in mM) 140
Na-gluconate, 2 Mg-gluconate2, 10 Hepes (at pH 7.1 with NaOH), and either
1 mM EGTA [to obtain “zero” (∼8 nM) Ca2+] or 1 mM Ca-gluconate2 (to
obtain 125 μM free [Ca2+]). Inward currents were recorded at 25 °C at
a membrane potential of −20 mV; the cytosolic face of the patch was con-
tinuously superfused (solution exchange time constant, <50 ms). Currents
were digitized at 10 kHz, filtered at 2 kHz, and recorded to disk. Na2-ADPR
was obtained from Sigma, and Na-AMPCPR was synthesized by Krzysztof
Felczak (University of Minnesota), as described (18).
Data Analysis. Macroscopic current relaxations were least-squares fitted by
single exponentials, and time constants after removal of AMPCPR were
normalized to those of bracketing control relaxations on removal of 32 μM
ADPR (Fig. S3A); averaged normalized time constants were rescaled by the
pooled average for all control relaxations. Fractional currents (Figs. 1G and
3C) were calculated by dividing mean current in a test segment by mean
current in 32 μM ADPR in the same patch. For steady-state single-channel
kinetic analysis (Figs. 5 and 6), well-resolved current segments from single-
channel (Fig. 5 A and B) or multichannel (Fig. S4 A and C) recordings were
Gaussian-filtered at 200 Hz and idealized by the half-amplitude threshold
method. The COC model was fitted to the events lists by maximum likeli-
hood (ref. 28; Fig. S4 B and D), and τo, τb, τib, τf, and nf (Fig. 6) were calcu-
lated from the fitted rate constants, as described (19).
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